Funds lagging for new stem cell centre

By Pete Young
Wednesday, 25 September, 2002

A skeleton administrative staff is at work on the $43.5 million National Stem Cell Centre even though Federal government has yet to sign a deed of agreement for the controversial research institute.

Without the deed, no public funding can flow to the projected centre.

Interim expenses are being met by bridging finance in the form of a loan account provided by Monash University.

Centre chairman Bob Moses said completing the deed of agreement was his first priority.

"Several issues need to be resolved and then in my view it will be ready for execution."

He declined to elaborate on which issues remain as sticking points.

The future of the centre is not formally tied to the passage of legislation governing embryonic stem cell research which is now before Federal Parliament. But failure to pass the legislation would effectively "tie one arm behind the back of a national stem cell centre," Moses said.

The state of limbo in which the centre currently sits is causing concern to some researchers who will be attached to it.

One is leading adult stem cell specialist, Assoc Prof Paul Simmons of the Peter McCallum Cancer Research Centre, sits on the centre's executive research committee.

In an exchange with Senator Brian Harradine during a recent Senate committee hearing on embryonic stem cell research, Simmons conceded he was becoming "anxious" about the funding issue for the centre.

No money was available to purchase equipment, he told Harradine.

However, Moses said the centre's organisers "are simply moving forward on the expectation that a deed of agreement will be signed shortly and funding provided as planned."

Related News

3D-printed films provide targeted liver cancer treatment

Researchers have created drug-loaded, 3D-printed films that kill more than 80% of liver cancer...

Using your brain at work may ward off cognitive impairment

The harder your brain works at your job, the less likely you may be to have memory and thinking...

Repurposed drugs show promise in heart muscle regeneration

The FDA-approved medications, when given in combination, target two proteins that regulate the...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd